Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022

Emerg Infect Dis. 2023 Nov;29(11):2395-2397. doi: 10.3201/eid2911.230499.

Abstract

Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous meropenem and colistin was successful. Carbapenem-resistant Salmonella Typhi emergence will hinder treatment.

Keywords: Pakistan; Salmonella Typhi; Salmonella enteria serovar Typhi; antimicrobial resistance; bacteria; carbapenem resistance; diagnosis; therapy; typhoid fever.

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems / pharmacology
  • Carbapenems / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Pakistan / epidemiology
  • Salmonella typhi / genetics
  • Typhoid Fever* / diagnosis
  • Typhoid Fever* / drug therapy
  • Typhoid Fever* / epidemiology

Substances

  • Carbapenems
  • Anti-Bacterial Agents